Cargando…
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128649/ https://www.ncbi.nlm.nih.gov/pubmed/32173287 http://dx.doi.org/10.1016/j.jgg.2020.02.001 |
| _version_ | 1783516611252060160 |
|---|---|
| author | Liu, Xin Wang, Xiu-Jie |
| author_facet | Liu, Xin Wang, Xiu-Jie |
| author_sort | Liu, Xin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7128649 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71286492020-04-08 Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines Liu, Xin Wang, Xiu-Jie J Genet Genomics Article Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. 2020-02-20 2020-02-13 /pmc/articles/PMC7128649/ /pubmed/32173287 http://dx.doi.org/10.1016/j.jgg.2020.02.001 Text en © 2020 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Liu, Xin Wang, Xiu-Jie Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title | Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title_full | Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title_fullStr | Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title_full_unstemmed | Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title_short | Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
| title_sort | potential inhibitors against 2019-ncov coronavirus m protease from clinically approved medicines |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128649/ https://www.ncbi.nlm.nih.gov/pubmed/32173287 http://dx.doi.org/10.1016/j.jgg.2020.02.001 |
| work_keys_str_mv | AT liuxin potentialinhibitorsagainst2019ncovcoronavirusmproteasefromclinicallyapprovedmedicines AT wangxiujie potentialinhibitorsagainst2019ncovcoronavirusmproteasefromclinicallyapprovedmedicines |